Risk of Alzheimer’s can be reduced by popular diabetes and weight-loss drug
The active ingredient in the diabetes and weight-loss medications Wegovy and Ozempic is semaglutide, a glucagon-like peptide receptor (GLP-1R) molecule that reduces appetite and aids in blood sugar regulation in type 2 diabetes.
